Introduction
Quality assurance in the treatment of cancer is gaining importance since many studies have shown variation in outcome between different providers. In Europe, quality assurance programmes have been introduced in the field of radiotherapy as well as for medical oncology, however, surgical quality control has received less attention.
1;2 Only recently, the European Society for Surgical Oncology (ESSO) has started an international audit program for rectal cancer treatment.
3;4 Few attempts have been made to spread the merits of quality assurance programmes to other tumour types.
Evidence-based guidelines that have been developed for a large variety of cancer treatments worldwide are seldom accompanied by well-defined standards for the evaluation of the quality of surgical care. Donabedian has conceptualized the evaluation of patient care in terms of structure, process, and outcome measures.
5
Oesophageal cancer ranks sixth on the list of cancer mortality worldwide. 6 In 2008, the incidence in the Netherlands was around 1850 patients per year. 7 It has been recommended to concentrate the surgical treatment of oesophageal cancer in high-volume. The effectiveness of such measures in raising the whole level of care has been questioned. 8 Preferably, the concentration of oesophageal cancer treatment is accompanied by a national quality assurance program, evaluating the different dimensions of quality of care in all hospitals taking care of these patients. 9 A practical definition of quality of care would be the degree to which health services achieve a level of care deemed adequate by evidence-based quality measures.
10
We have performed a review of the literature to identify evidence-based standards for high-level quality of care for oesophageal cancer patients who are candidates for surgical therapy. We used the Donabedian quality-of-care model to categorize the identified standards. Furthermore, we aimed to construct a minimum dataset of evidence-based quality-of-care indicators for future registration and benchmarking.
Materials and Methods

Search strategy
A search of the literature on PubMed was performed to find articles published between January 1990 and October 2009 on quality of care in the surgical treatment of oesophageal cancer. Three Medical Subject Heading (MeSH) terms were used: 'oesophageal neoplasms', 'surgery' and 'oesophagectomy'. Studies describing aspects of quality of care were searched by combining these three MeSH terms with the following keywords: 'benchmarking', 'health care', 'hospital mortality', 'hospitals', 'medical audit', 'outcome and process assessment (health care)', 'postoperative complications', 'quality assurance', 'quality indicators', 'referral and consultation'. Articles were selected on the basis of their relevance using pre-defined in-and exclusion criteria (Figure 1 ). Many studies were excluded because they were noncomparative studies. Only original articles were considered for inclusion. Selection was performed independently by two investigators (ECS and MW). A third reviewer (JvS) was consulted in case of disagreement. One hundred thirty articles were included. 
Level of evidence
Of 130 included articles, 13 were randomised controlled trials, 26 were prospective (cohort) studies and 91 were retrospective studies. Because of the comparable level of evidence for most of these included studies, we classified results of evidence according to a scoring system used in a previous article by Lagarde et al: none (no evidence), minor (only evidence from univariate analysis), considerable (evidence from uni-and multivariate analysis), strong (evidence from several multivariate analyses or evidence from univariate analysis in at least ten articles).
11
Only characteristics with strong evidence or those with considerable evidence based on at least three articles were entered into a minimum dataset of 'evidence-based' qualityof-care indicators for oesophageal cancer surgery.
Structural measures
Structural variables with corresponding articles are listed in Table 1 .
Volume
A wide variation in definitions of hospital volume was found in the various studies on hospital volume and mortality rates (e.g., the definition of high-volume ranged from 6 to 40 resections per year).
12-36 Besides the clear association between high volume and low mortality rates, also lower complication rates and shorter admission times have been found in high-volume hospitals as compared to low-volume hospitals. 12;15;23;24;34;35;37;38 Consequently, treatment in high-volume hospitals has been associated with a decrease in hospital charges.
12;14-16;18
Other clinical endpoints, such as long-term survival and quality of life, have been studied less often. Two out of three studies 20;39;40 could not demonstrate a survival benefit in high-volume hospitals 20;39 and one other study did not find an improved quality of life.
41
As in studies on the influence of hospital volume, higher annual case volume per surgeon has been associated with lower postoperative mortality rates. 
Organization
Few studies specifically addressed the impact of organization of care on the outcome of surgically treated oesophageal cancer patients. In one study, daily rounds by an ICU physician were associated with shorter lengths of stay, lower hospital cost, and less postoperative complications after oesophageal resection, but not with a lower in-hospital mortality rate. 51 In an other large study, a comparison between 225 patients with a nighttime nurse-to-patient ratio of 1:1 or 1:2 and 128 patients with a night-time nurse-to-patient ratio of 1:3 or more was made. 52 Patients in the second group had an increased risk of postoperative complications after oesophageal resection which was associated with an increased use of resources.
Centralization
Following the relationship between volume/specialization and outcome, one may expect that centralization of oesophagectomies at high-volume providers improves outcome. Few studies have actually demonstrated this. 
Process measures
Process variables with corresponding articles are listed in Table 2 .
Patient selection
In several studies, the influence of old age was investigated. The use of a risk score may be a quality indicator. Bartels et al evaluated a risk scoring model in a prospective setting and found a marked reduction in post-operative deaths due to better patient selection.
67
The relationship between the preoperative nutritional status and the outcome of surgery in patients with oesophageal carcinoma has shown conflicting results.
68-71 In one study, underweight patients who underwent major intra-abdominal surgery, e.g., oesophagectomy, had a five-fold increased risk of postoperative mortality. 69 Though, other studies including exclusively oesophageal cancer patients have not confirmed this. 68;70 In four studies, complication rates for obese patients equalled those for non-obese patients.
68-71
The role of race and socio-economic status on patient selection has received some attention. It has been suggested that patients' but possibly also physicians' preferences might differ among different socio-economic groups of patients.
74
In one study, there was a relationship between better pretreatment quality of life and lower postoperative mortality.
76 Especially reduced physical function as an aspect of pretreatment quality of life was predictive of lower survival in several studies.
77-80
Staging
For high-risk surgical procedures, it is important to select only those patients who can be cured. For computed tomography (CT) examination, the level of experience of the radiologist appeared to influence the detection of metastases in patients with oesophageal cancer.
81
Fluorodeoxyglucose positron emission tomography (FDG-PET) has shown its incremental value with the identification of 5 to 17% additional patients with metastases. 
Peri-operative care
Watson et al showed that respiratory complications decreased from 30 to 13% and death due to these complications from 5 to 0%, after introducing the routine use of thoracic epidural analgesia (TEA). 114 In an other series, TEA lowered the anastomotic leakage rate. 115 The authors suggested a causal relationship between hypoxemia and hypotension due to respiratory hypofunction in patients undergoing oesophagectomy without the use of TEA. It has also been shown that the use of TEA enables early discharge of patients after oesophagectomy. None: no evidence; minor: only evidence from univariate analysis; considerable: evidence from uni-and multivariate analysis; strong: evidence from several multivariate analyses or evidence from univariate analysis in 10 or more articles. 
Pathology reporting
Histopathological assessment of the resection specimen plays an important role in patient management, in confirming whether complete excision has been achieved and in providing essential information on pathological tumour-node-metastasis (TNM) staging. The need to improve the quality of pathology reporting in oesophageal cancer management has been recognised.
117;118
Outcome measures
Outcome variables with corresponding articles are listed in Table 3 .
ICU stay
Length of ICU stay did not influence patients' survival and long-term quality of life.
119
Postoperative complications
The occurrence of postoperative complications after oesophageal cancer surgery has not only been associated with higher postoperative mortality rates and increased use of resources, but also with worse survival.
38;120-129
Radicality of resection
Multiple studies [130] [131] [132] [133] [134] [135] [136] have shown the independent prognostic value of a microscopically radical (R0) resection.
130-137
Number of resected lymph nodes
The number of identified lymph nodes is an independent predictor of survival after oesophagectomy for cancer. [138] [139] [140] According to Peyre et al, a minimum of 23 lymph nodes should be resected.
140
'Evidence-based' quality indicators for oesophageal cancer surgery A minimum dataset of 'evidence-based' quality-of-care indicators for the surgical treatment of oesophageal cancer was created based on the identified standards with strong evidence or those with considerable evidence in at least three articles. This dataset is presented in Table 4 . 
Discussion
This has been the first review of the literature to identify evidence-based standards for highlevel quality of care for oesophageal cancer patients who are candidates for surgery. Results show that (1) there is strong evidence that both hospital and surgeon volume are important determinants for postoperative mortality, (2) other structural measures, e.g., infrastructure and organization of oesophageal cancer surgery, have been less frequently investigated, (3) the most commonly reported process measures were determinants of patient selection for surgery (e.g., patients' age), (4) other process indicators with considerable evidence were found (e.g., multidisciplinary team management), though the number of studies was small, and (5) the level of evidence for pathological outcome measures was high.
Structural measures
A plethora of studies concerning the volume-outcome relationship for oesophageal cancer surgery was found. High-volume and specialized care were mostly related to a decreased postoperative mortality, and, in a lesser extent, to lower postoperative morbidity, shorter hospital stay, better survival and lower costs. Volume is only a surrogate for high-level processes of care and does not reveal the mechanisms behind the better outcomes.
There is evidence that centralization of oesophageal cancer resections leads to substantial improvements in outcome. Such efforts have been accompanied by continuous measurement and feedback of process and outcome indicators to individual surgeons and their referring colleagues. Only then, improvements in outcome are to be expected. 9 Data on infrastructural or organizational characteristics that lead to success or failure, were very limited (e.g., ICU staffing) or absent (e.g., ICU level).
Process measures
Evidence was found that teams using a risk score for the selection of surgical patients can decrease their postoperative mortality rates. Age, nutritional or socio-economic status should not be used as selection criteria for oesophageal cancer surgery. On the other hand, in assessing resection rates or surgical outcome, these factors are to be included as case-mix variables. Preoperative feeding to prevent further deterioration of the nutritional state of patients presenting with obstructive symptoms and weight loss could be a valid quality indicator, but the level of evidence for a better outcome is low.
69
We found evidence -although limited-that volume and experience play a role in the staging process of patients with oesophageal cancer.
81;90 It would be better to assess the whole staging process by calculating the percentage of patients in whom a futile operation has been performed due to inadequate staging. Neoadjuvant chemoradiation followed by surgery was associated with similar postoperative mortality rates as surgery alone in all studies, and survival rates improved in two studies.
94;105 If neoadjuvant chemoradiation becomes standard of care, there is a need to formulate quality indicators for its use (e.g., toxicity criteria). Diagnosis and treatment of oesophageal cancer patients by a dedicated multidisciplinary team could be an important quality indicator, but this is supported by only one paper.
108
Not only the expertise of the surgeon, but also that of the radiologist, anaesthesiologist, ICU-physician and nurses contribute to the outcome of surgery.
There is considerable evidence that the transhiatal approach leads to a reduced postoperative morbidity rate. [109] [110] [111] [112] Presumed that the transthoracic approach with an extended lymphadenectomy is technically more challenging, one could propose that the performance of transthoracic oesophagectomies in patients with a tumour located in the distal oesophagus should be regarded as a quality indicator. No studies were found on other process indicators such as waiting times or psychological guidance during treatment.
Outcome measures
Outcome measures, like postoperative complication rates, tumour negative surgical margins, and number of retrieved lymph nodes are plausible measures of quality of care for physicians and their patients.
Further investigation is warranted to look for additional valid outcome parameters of quality of care (e.g., hospital readmission rates, pain scores, number of anastomotic dilatations).
Limitations
A major limitation to this review is that there is no MESH term for "quality of care". We have tried to give an overview of the available literature on evidence-based determinants for high-leverage quality of care, but our review may have been biased by the choice of our search terms. Secondly, case-mix plays an important role in evaluating differences in outcome after oesophageal cancer surgery. Consequently, for many studies, with a lack of information on patients' co-morbidity, tumour stage distribution, and patient selection criteria, the conclusions are debatable.
Future directions
The uniform use of well-defined quality-of-care indicators to measure and document practice performance holds the promise of improving outcomes in patients who undergo surgical treatment for oesophageal cancer. Recently, another evidence-based review of oesophageal cancer surgery was published. 148 In this review, non-surgical issues were not addressed. The present review places oesophageal cancer surgery in a broader perspective. Improving the level of care for surgical oesophageal cancer patients is a team effort from diagnosis, staging and risk assessment to follow-up and management of late sequelae of treatment. Ideally, each step is monitored by a set of measurable elements which reflect the quality of care. Several projects have been started in which quality indicators are to be developed, not only based on evidence from the literature, but also on consensus of experts in the field. In Denmark, the Danish National Indicator Project has shown that continuous performance and outcome measurement, using clinical indicators is possible and fruitful in terms of quality improvement. 149 Recently, Bilimoria et al presented an extensive set of quality indicators for pancreatic cancer. 150 After reviewing the literature for potential quality indicators, a Delphi method was used to develop quality indicators consulting several expert panels. In our opinion, a similar procedure should be pursued for oesophageal cancer care. To benchmark the outcome of consensus-based quality indicators, multi-centred data-collection, dataanalysis and feedback of individual data is essential to provide physicians with actionable information about their quality of care.
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